J
Jonas Jögi
Researcher at Lund University
Publications - 61
Citations - 2323
Jonas Jögi is an academic researcher from Lund University. The author has contributed to research in topics: Ventilation/perfusion ratio & Positron emission tomography. The author has an hindex of 23, co-authored 54 publications receiving 1654 citations.
Papers
More filters
Journal ArticleDOI
Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders
Rik Ossenkoppele,Rik Ossenkoppele,Gil D. Rabinovici,Ruben Smith,Hanna Cho,Michael Schöll,Michael Schöll,Olof Strandberg,Sebastian Palmqvist,Niklas Mattsson,Shorena Janelidze,Alexander Santillo,Tomas Ohlsson,Jonas Jögi,Richard M. Tsai,Renaud La Joie,Joel H. Kramer,Adam L. Boxer,Maria Luisa Gorno-Tempini,Bruce L. Miller,Jae Y. Choi,Young Hoon Ryu,Chul Hyoung Lyoo,Oskar Hansson +23 more
TL;DR: Among patients with established diagnoses at a memory disorder clinic, [18F]flortaucipir PET was able to discriminate AD from other neurodegenerative diseases, and the accuracy and potential utility of this test in patient care require further research in clinically more representative populations.
Journal ArticleDOI
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
Niklas Mattsson,Michael Schöll,Olof Strandberg,Ruben Smith,Sebastian Palmqvist,Philip S. Insel,Philip S. Insel,Douglas Hägerström,Tomas Ohlsson,Henrik Zetterberg,Jonas Jögi,Kaj Blennow,Kaj Blennow,Oskar Hansson +13 more
TL;DR: It is concluded that CSF T‐t Tau and P‐tau mainly behave as biomarkers of “disease state”, since they appear to be increased in many cases of AD at all disease stages, already before the emergence of tau aggregates.
Journal ArticleDOI
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
Michael Schöll,Michael Schöll,Rik Ossenkoppele,Olof Strandberg,Sebastian Palmqvist,Jonas Jögi,Tomas Ohlsson,Ruben Smith,Oskar Hansson +8 more
TL;DR: Preliminary findings indicate that age may constitute an important contributor to Alzheimer's disease heterogeneity highlighting the potential of tau positron emission tomography to capture phenotypic variation across patients with Alzheimers disease.
Journal ArticleDOI
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Antoine Leuzy,Ruben Smith,Rik Ossenkoppele,Rik Ossenkoppele,Alexander Santillo,Edilio Borroni,Gregory Klein,Tomas Ohlsson,Jonas Jögi,Sebastian Palmqvist,Niklas Mattsson-Carlgren,Olof Strandberg,Erik Stomrud,Oskar Hansson +13 more
TL;DR: It is suggested that RO948 F 18 has a high specificity for Alzheimer disease–type tau and its potential as a diagnostic marker in the workup of patients treated in memory clinics is highlighted.
Journal ArticleDOI
Increased basal ganglia binding of 18F‐AV‐1451 in patients with progressive supranuclear palsy
Ruben Smith,Martin Schain,Christer Nilsson,Olof Strandberg,Tomas Olsson,Douglas Hägerström,Jonas Jögi,Edilio Borroni,Michael Schöll,Michael Schöll,Michael Honer,Oskar Hansson +11 more
TL;DR: The recently developed tau PET tracers may improve the diagnostic work‐up of PSP and help diagnose the disease more accurately.